LifeStance Health (LFST) Accumulated Expenses (2020 - 2026)

LifeStance Health (LFST) has 7 years of Accumulated Expenses data on file, last reported at $117.3 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $117.3 million, up 17.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $117.3 million (up 17.4% YoY), and the FY2025 annual result was $143.3 million, up 22.02% from the prior year.
• Accumulated Expenses retreated to $117.3 million in Q1 2026 per LFST's latest filing, from $143.3 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $143.3 million in Q4 2025 and troughed at $61.2 million in Q2 2022.
• A 5-year average of $98.7 million and a median of $100.4 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses surged 51.06% in 2024, then slipped 0.51% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $75.6 million in 2022, then surged by 35.46% to $102.5 million in 2023, then gained by 14.62% to $117.5 million in 2024, then grew by 22.02% to $143.3 million in 2025, then declined by 18.15% to $117.3 million in 2026.
• Business Quant data shows LFST's Accumulated Expenses at $117.3 million in Q1 2026, $143.3 million in Q4 2025, and $113.8 million in Q3 2025.